To maximize pollutant removal efficiency with minimal energy consumption, electrochemical process for wastewater treatment should be further conducted. The stepping control of electrochemical process for simultaneous removal of chemical oxygen demand (COD) and ammonia from simulated and actual wastewater with high efficiency and energy saving was studied in this work. Flow rate, initial pH value, Cl− concentration, and applied current density were determined to be the influencing factors for the degradation performance, and analyses of pollutant removal efficiency further revealed that applied current density was the significant parameter in this case. A stepping control system by operating applied current density timely based on the degradation pathway of organic matter and variation of anodic working potential was then proposed; results indicated that 90.9% COD and 100% ammonia could be removed, and energy consumption of 7.6 kWh m−3 was calculated, which was substantially lower than that of the traditional electro-oxidation system (11.7 kWh m−3). Additionally, the developed stepping control system was validated by treating an actual pharmaceutical wastewater, results for which showed that removal efficiencies of 81.7% and 100% were achieved for COD and ammonia, respectively, and energy saving could be up to 37.2%.

In recent years, vascular depression has become the focus of international attention. Yangxinshi Tablet (YXST) is usually used in cthe linic for the treatment of arrhythmia and heart failure, but we found that it also has antidepressive effects. The objective of the study was to identify biomarkers related to vascular depression in hippocampus and explore the antidepressive effects of YXST on the mouse model. Untargeted metabolomics based on UHPLC-Q-TOF/MS was applied to identify significantly differential biomarkers between the model group and control group. Unsupervised principal component analysis (PCA) was used to scan the tendency of groups and partial least squares-discriminant analysis (PLS-DA) to distinguish between the vascular depressive mice and the sham. PCA stores showed clear differences in metabolism between the vascular depressive mice and sham groups. The PLS-DA model exhibited 38 metabolites as the biomarkers to distinguish the vascular depressive mice and the sham. Further, YXST significantly regulated 22 metabolites to normal levels. The results suggested that YXST has a comprehensive antidepressive effect on vascular depression via regulation of multiple metabolic pathways including amino acid, the tricarboxylic acid cycle and phosphoglyceride metabolisms. These findings provide insight into the pathophysiological mechanism underlying vascular depression and the mechanism of YXST.

No abstract

No abstract

No abstract